--2025/Q1-- / 0.000--
--2024/Q4-- / 300.000K--
--2024/Q30.000 / 300.000K--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
RNAZ Transcode Therapeutics
- 3.580
- -0.180-4.79%
Close Dec 23 16:00 ET
- 3.580
- 0.0000.00%
Post 16:03 ET
2.49MMarket Cap-0.13P/E (TTM)
3.835High3.540Low64.67KVolume3.760Open3.760Pre Close234.00KTurnover9.29%Turnover Ratio0.00P/E (Static)696.25KShares236.94052wk High1.51P/B2.49MFloat Cap3.21052wk Low--Dividend TTM696.06KShs Float184800.000Historical High--Div YieldTTM7.85%Amplitude3.210Historical Low3.618Avg Price1Lot Size
Transcode Therapeutics Key Stats
Transcode Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Transcode Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data